LDLR and type 2 diabetes mellitus: An increase in M2 macrophages was also observed upon DPP4 inhibitor treatment in another atherosclerosis model using LDLR-/- mice [43], moreover, a recent meta-analysis showed a decreased infection rate in T2DM patients treated with a DPP4 inhibitor [44].